Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Industry Specialization, Consolidation Driven By Rising Product Complexity

Executive Summary

The generic market is moving toward more complex products and formulations, which will separate companies based on capabilities, CEOs said at the Generic Pharmaceutical Association annual meeting.

Advertisement

Related Content

Entering The Generics Business In Mature Markets: Lessons Learned From 4,500 Launches
Are Potential Biosimilar Sponsors Still Hesitant About The Pathway Despite Expected Growth?
Are Potential Biosimilar Sponsors Still Hesitant About The Pathway Despite Expected Growth?
Hamburg Trumpets Potential Rewards Of Quality Improvement For Generic Industry
Merck Partners With Korea’s Samsung Bioepis On Multiple Biosimilar Targets
Mylan And India’s Biocon Team Up To Develop Insulin Biosimilars Of Sanofi, Lilly, Novo Nordisk Products
Biosimilar User Fee Meeting Schedule Allows FDA Data “Pre-Review”
Biosimilar Players Will Be Manufacturers Large And Small, Analyst Predicts
FDA Envisions Many Regulatory Coalitions Dealing With Globalization Issues

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS055154

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel